Prometal

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prometal

What is Prometal? Defining the Antihistamine Class

Property Description
Active ingredient Promethazine hydrochloride
Form Tablets, Syrup, Solution for injection, Suppositories
Pharmacological class First-generation antihistamine
General purpose Allergy relief, sedation, anti-nausea action
Origin Synthetic (Phenothiazine derivative)

Prometal is a preparation whose core component is Promethazine hydrochloride, a synthetic compound classified as a first-generation antihistamine. This substance belongs to the phenothiazine derivative chemical group.

Promethazine is clinically recognized for its triple action: it functions primarily as an H1-receptor antagonist to block histamine, but it also has strong sedative and antiemetic (anti-nausea) properties. This unique profile, stemming from its ability to affect the Central Nervous System (CNS), distinguishes it from newer, less sedating antihistamines. Promethazine is widely used globally under various trade names, such as Phenergan, underscoring its broad acceptance in medicine.

Composition and Available Preparations of Promethazine

The medicine is based on the Promethazine hydrochloride salt form and is supplied in multiple common dosage forms to ensure flexible administration across different patient needs.


As a single-ingredient product, the effects are derived solely from Promethazine. It is manufactured as tablets and syrup for oral intake, as well as a solution for injection for parenteral administration, and in suppositories for rectal use. The availability of multiple preparations ensures the medicine can be delivered systemically, even in scenarios involving severe nausea where oral dosing is difficult.

The General Purpose of This Compound

The general purpose of Promethazine is defined by its ability to provide comprehensive relief through its combined pharmacological actions.


This compound is often used to generally help manage allergic conditions by providing histamine blockade. Furthermore, it is effective for preventing or controlling nausea and vomiting, especially post-operative or motion-related sickness. Its inherent sedative properties also make it suitable for general use when a temporary reduction in apprehension or the promotion of sleep is desired.

What side effects are possible with Prometal?

Classification of Adverse Reactions by Body System

The general principles of how adverse effects appear in clinical use involve classifying them according to the physiological system they affect and estimating their frequency based on observed data from regulatory documents. The most prominent and widely reported adverse effect of Prometal (promethazine) is sedation or somnolence, which is classified as a very common adverse reaction (occurring in 1 or more in 10 patients) in official prescribing information.

Other documented side effects are typically grouped by the System-Organ Class (SOC):

System-Organ Class Officially Documented Adverse Reactions (Frequency Not Known unless noted)
Nervous System Disorders Drowsiness (Very Common), Dizziness, Confusion, Extrapyramidal Symptoms, Convulsive Seizures
Psychiatric Disorders Hallucinations, Excitation, Agitation, Nightmares
Gastrointestinal Disorders Dry mouth, Nausea, Vomiting, Constipation
Blood and Lymphatic System Disorders Leukopenia, Agranulocytosis, Thrombocytopenia
Skin Disorders Photosensitivity, Dermatitis, Rash

Documented Serious Adverse Reactions and Safety Constraints

Official regulatory documents highlight critical, serious adverse reactions. Promethazine carries warnings for potentially fatal respiratory depression, particularly concerning use in compromised patients. Neuroleptic Malignant Syndrome (NMS), a potentially fatal complex, has also been reported in association with its use. For the injectable formulation, there is a risk of severe tissue injury and gangrene; due to this, subcutaneous and intra-arterial administration are strictly contraindicated.

Safety constraints exist for specific populations. The medicine is contraindicated in pediatric patients less than two years of age across all formulations due to the risk of fatal respiratory depression. Additionally, caution is required in older adults due to increased sensitivity to central nervous system (CNS) and anticholinergic effects.

Overdose and Emergency Response

Overdose and When to Seek Help

The occurrence of overdose with Prometal (promethazine) requires immediate recognition of specific clinical signs and mandated emergency action. Regulators require seeking immediate medical attention and contacting emergency services if signs such as trouble breathing or slowed breathing, having a seizure, collapse, or loss of consciousness occur.

Overdose manifestations officially documented across regulatory labels include a dual presentation of effects on the Central Nervous System (CNS): profound drowsiness progressing to coma, or conversely, paradoxical CNS excitation with agitation and hallucinations. Other frequently cited signs involve anticholinergic effects such as mydriasis (dilated pupils), dry mouth, and urinary retention.

Severe or life-threatening outcomes specifically documented include potentially fatal respiratory depression, which has been associated with death, and severe cardiovascular events, notably severe hypotension and serious cardiac arrhythmias.

For management, no specific antidote is known for Promethazine overdose. Therefore, the required clinical approach centers exclusively on symptomatic and supportive treatment, including airway support and continuous ECG monitoring in a hospital setting.

A critical population-specific note from regulatory documents highlights the heightened vulnerability of children, citing risks of sudden death and fatal respiratory depression.

Therapeutic Uses of Prometal

Prometal (promethazine) is relevant for easing symptoms related to systemic imbalance. The medication is considered helpful for addressing symptoms that create noticeable functional strain or discomfort.

Symptomatic Relief for Allergic Conditions

Prometal is commonly used to address pronounced symptoms of allergic reactions, including excessive sneezing, rhinorrhea (runny nose), and the intense itching and discomfort associated with uncomplicated skin conditions like hives. It may be part of symptomatic management that assists patients in coping more steadily with these difficult episodes, helping improve day-to-day comfort during periods of high allergen exposure.


Managing Nausea, Vomiting, and Equilibrium Distress

This medication is commonly used in clinical settings to help with acute episodes of nausea, vomiting, and dizziness, particularly those triggered by motion or associated with surgical procedures. The core therapeutic contexts include the symptomatic management of allergic manifestations, supportive management of motion sickness, addressing active vomiting, and assisting with short-term pre- and post-operative sedation.

“It helps with supporting stability during acute emetic episodes.”

It offers supportive therapeutic benefit by easing the impact of emetic manifestations on functional stability and contributes to improved comfort during periods of heightened discomfort.


Short-Term Support for Rest and Apprehension

Prometal is relevant in situations where patients require temporary assistance in symptom stabilization, such as assisting with pre-operative anxiety or supporting the achievement of short-term, quiet sleep when restlessness is a factor. It may assist with supporting stability and provides support that helps ease the overall burden of apprehension or restlessness when symptoms become momentarily overwhelming.


Quick Fact: Relief for Itching and Vomiting

Therapeutic Focus Common Symptoms Addressed
Allergy & Skin Intense itching, sneezing, watery eyes
Nausea & Motion Vomiting, dizziness, motion sickness
Sedation Restlessness, pre-procedural apprehension

Regulatory References

  1. DailyMed Label from the National Library of Medicine

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Prometal (Promethazine) — Official Regulatory Information

This section outlines the population eligibility and non-eligibility criteria for Prometal, based strictly on authoritative government regulatory documents.


Eligibility Scope

Category Official Regulatory Statement
Populations for whom use is allowed Adults and adolescents without documented contraindications. Pediatric patients aged 2 years and older (under strict clinical supervision).
Populations for whom use is contraindicated Pediatric patients younger than 2 years of age (absolute prohibition due to risk of fatal respiratory depression). Patients in a comatose state or with severe CNS depression. Individuals with known hypersensitivity to promethazine or phenothiazines.
Age-related eligibility rules Prohibited for use in infants under 2 years of age. Caution is required for use in older adults (Geriatric population) due to increased susceptibility to side effects like confusion and sedation.
Condition-specific eligibility rules Contraindicated in the presence of lower respiratory tract symptoms (e.g., asthma, status asthmaticus). Use is restricted in patients with severe breathing problems or sleep apnea.
Pregnancy and lactation eligibility status Pregnancy: Use is restricted/not recommended near term. Lactation: Use is not recommended/should be avoided.

Connection to the overall eligibility profile

Official regulatory documents define the overall eligibility profile by imposing non-negotiable absolute contraindications for infants under 2 years old and patients with severely compromised CNS or respiratory function. Furthermore, the profile establishes restricted use categories for older adults, pregnant or lactating women, and individuals with specific comorbidities such as glaucoma or prostatic hypertrophy, confining established use to patients who do not possess these documented high-risk characteristics.

What should I know about interactions with other medicines?

The interaction profile for Prometal (promethazine) is defined by officially documented Pharmacodynamic Reinforcement and specific regulatory restrictions, based on product labeling from government authorities.

Interaction Scope

Category Officially Documented Interacting Substances
CNS Depressants Alcohol, Opioids, Sedatives, Hypnotics, General Anesthetics, Barbiturates
Anticholinergic Agents Agents with significant anticholinergic properties
Hypotensive Agents Antihypertensives, Sympathomimetic Agents (Epinephrine)
Metabolic Pathway Propranolol (inhibition of metabolism); Promethazine is predominantly metabolized by CYP2D6.

Interaction-Related Restrictions and Classifications

  • Contraindicated Combination: Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly prohibited. Following the discontinuation of an MAOI, a 14-day washout period is required before starting Prometal therapy.
  • Additive Effects: Prometal may increase, prolong, or intensify the sedative effects of Alcohol and other CNS Depressants, leading to amplified impairment. Similarly, combining with other Anticholinergic Agents increases the risk of cumulative anticholinergic effects.
  • Procedural Constraint: Epinephrine should not be used to treat hypotension associated with Promethazine due to the potential for Promethazine to reverse its vasopressor effect.
  • Population Note: Geriatric patients may have heightened susceptibility to the CNS depressant and anticholinergic effects of documented interactions.

Connection to the overall interaction profile (2–4 sentences): Regulatory documents define the product’s interaction structure primarily through two significant Pharmacodynamic Reinforcement domains: the additive effects with CNS Depressants and the cumulative risk with Anticholinergic agents. A critical Contraindicated Combination is established with MAOIs, necessitating a defined timing-based separation rule of 14 days. A specific regulatory note also exists for co-administration with the beta-blocker Propranolol, which is noted to increase the exposure of both substances.

Mechanism of Action

Dual Blockade of Central Arousal and Emetic Pathways

Prometal's mechanism is defined by broad-spectrum antagonism of neurotransmitter receptors, including the Histamine H1 receptor and Muscarinic acetylcholine receptors ( M), in both central and peripheral nervous systems. The molecule's ability to cross the Blood-Brain Barrier (BBB) allows it to depress neuronal activity in the Reticular Activating System (RAS), resulting in systemic reduction of vigilance and excitability. Simultaneously, antagonism of the Dopamine D2 receptor in the Chemoreceptor Trigger Zone (CTZ) inhibits signals that normally trigger the emetic reflex arc, resulting in functional inhibition of the vomiting center.


Modulating Systemic Signaling and Vascular Tone

The mechanism of action extends beyond the central pathways to include inhibitory activity on Alpha-1 adrenergic receptors ( alpha1) and H1 receptors in peripheral tissues. By blocking H1 receptors, Prometal antagonizes the activation of cellular responses mediated by histamine, including effects on capillary permeability and nerve ending stimulation. The parallel alpha1 blockade interferes with the signaling cascade that regulates vasoconstriction, resulting in a modulation of systemic vascular tone.

Dosage and Administration Information

Prometal (promethazine hydrochloride) is administered through several approved routes, including oral (tablets or syrup), rectal (suppositories), and parenteral via deep intramuscular (IM) or slow intravenous (IV) injection. Subcutaneous and intra-arterial routes are strictly prohibited. Dosing is highly regimen-specific and is generally intended for short-term use.

For allergic conditions, the standard adult regimen is 25 mg taken once daily at bedtime, or 6.25 mg to 12.5 mg in divided doses before meals and at night. When managing acute nausea and vomiting, an initial dose of 12.5 mg to 25 mg is used, which may be repeated every four to six hours as needed. The maximum total daily dose for adults is limited to 100 mg. Prometal may be taken with food, water, or milk to help reduce possible gastrointestinal discomfort.

Parenteral administration requires specific handling protocols. The deep intramuscular route is preferred over the intravenous route. If administered intravenously, the solution must be diluted and injected into a large, patent vein at a slow rate, not exceeding 25 mg per minute. Regarding specific populations, the medicine is excluded from use in children younger than two years of age. For pediatric patients aged two years and older, dosing for certain uses is calculated based on body weight. The dose should always be adjusted to the minimum amount necessary to relieve symptoms.

Recent Clinical Evidence

Research evidence / Overview of Studies for Prometal

Prometal (promethazine) has been studied in clinical research, including randomized controlled trials (RCTs) and systematic reviews, to understand the outcomes measured in research for several key conditions. The available evidence provides context on how the medicine has been evaluated in different patient groups and for various conditions characterized by fluctuating or episodic manifestations.

Research examining symptomatic allergic conditions and acute nausea/vomiting has primarily relied on short-term Randomized Controlled Trials (RCTs). Studies explored outcomes related to physical discomfort (e.g., itching, sneezing) and changes in emetic episodes (vomiting frequency). For short-term sedation, RCTs focused on observing changes in anxiety scores and restlessness before medical procedures. Research has also been conducted for motion sickness, with studies focusing on pre-exposure outcomes in controlled settings. A consistent finding across many trials was that the compound was associated with the occurrence of increased drowsiness and sedation.

Overall, follow-up durations were limited in the primary research for all indications, meaning long-term effects are not fully established. Evidence involving special populations, such as children aged 2 years and older and hospitalized pregnant women, has been evaluated. However, research exploring short-term symptom changes in children under 2 years is limited, and this age group is typically not included in the established regulatory evidence. Key limitations include modest sample sizes in some older trials, variability in evidence quality, and the high rate of associated sedation.

Key Studies & References PROMETHAZINE HYDROCHLORIDE tablet, solution, syrup, and suppository (DailyMed Label)

Frequently Asked Questions (FAQ)

Common questions about Prometal (FAQ)


Q: How quickly can I expect Prometal to start working?

Official product information indicates that the effects of Prometal generally begin relatively quickly, often within about 20 minutes after taking the medicine. While the intended effect may be noticeable soon after, the full pharmacological effect may be noticeable for several hours. The sedative effect, which is very common, may persist for a longer period.


Q: How long does Prometal stay in your system?

According to regulatory pharmacokinetics data, Prometal has a reported half-life that typically ranges between 7 and 14 hours. The medicine is primarily metabolized (broken down) in the liver. The resulting inactive substances are then largely excreted from the body in the urine and feces.


Q: Is Prometal the same kind of medicine as [similar drug name]?

Prometal's active component, promethazine hydrochloride, is officially defined as a first-generation antihistamine. It also belongs to a class of compounds called phenothiazine derivatives. This classification describes the specific chemical structure and the multiple ways the medicine acts in the body.


Q: What makes Prometal different from other medicines for this condition?

Regulatory documents describe Prometal as having a triple action profile. In addition to blocking histamine receptors, it also provides a strong effect in reducing nausea and vomiting (antiemetic action) and causes central nervous system depression, which results in significant sedation. The specific combination of these effects determines its clinical applications.


Q: Are there any warnings about driving or operating machinery while on Prometal?

Yes, the official warnings and precautions section includes a specific note about activities requiring full alertness. Because Prometal can frequently cause drowsiness or dizziness, official warnings state that activities requiring full attention, such as driving or operating heavy machinery, should be avoided while using this medicine.


Q: Why is Prometal taken once a day?

The standard dosing schedule for treating allergic conditions is often outlined in official directions as a single dose taken at bedtime. This timing in the official directions helps accommodate the potential for the medicine's very common side effect of drowsiness. It also aligns with the medicine's duration of effect.


Q: Are the initial side effects of Prometal different from long-term side effects?

Regulatory documents note that the most immediate and frequent effect is drowsiness, classified as very common. Other documented adverse reactions, such as those related to blood disorders or psychiatric changes, are less common and are listed separately. Research evidence indicates that long-term effects beyond short-term use are not fully established.


Q: Is the maximum effect of Prometal seen after a certain period of use?

Clinical research has historically examined Prometal in short-term randomized trials for managing acute symptoms, such as episodic nausea or acute allergy flare-ups. This suggests that the medicine’s therapeutic use is generally focused on managing immediate symptoms rather than requiring long periods for accumulation.


Q: Is Prometal available over the counter?

Prometal is not available for purchase without a medical professional’s prescription. The compound is classified as a prescription-only medicine in regulatory documents due to its specific safety constraints and potential for significant central nervous system effects.


Q: Does Prometal cause weight gain or loss?

The list of documented adverse reactions associated with Prometal does include changes in appetite. However, official information does not list either weight gain or weight loss as a very common or highly frequent side effect of the medicine.


Q: Is there a generic version of Prometal?

Yes, the active ingredient in the medication is promethazine hydrochloride. This compound is widely available as a generic medicine and is used globally under various trade names besides Prometal.


Q: Are there any food restrictions when using Prometal?

Official prescribing information indicates that Prometal may be taken with food, water, or milk. This is noted as an option to potentially reduce gastrointestinal discomfort. Regulatory documents do not list specific dietary restrictions that must be followed.


Q: Does Prometal affect sleep patterns?

Prometal is known for its strong sedative properties, which can be used to help promote sleep or reduce apprehension. However, regulatory adverse reaction reports also list potential effects on the nervous system, including psychiatric disturbances such as nightmares, agitation, or confusion.


Q: Has Prometal been studied in children or adolescents?

Regulatory evidence and clinical studies have focused on pediatric patients who are aged 2 years and older. The medicine is subject to an absolute contraindication (prohibition) for use in any child younger than two years of age due to the risk of potentially fatal respiratory depression.


Q: How is Prometal eliminated from the body?

Prometal is primarily processed and broken down by metabolic enzymes in the liver. The resulting inactive substances are then eliminated from the body. These substances are excreted primarily through the urine and, to a lesser extent, in the feces.


Q: Can women who are pregnant or planning to be pregnant take Prometal?

The official eligibility profile restricts the use of Prometal in pregnant women. Specifically, the medicine is not recommended for use near term (in the final weeks of pregnancy). Additionally, official regulatory guidance indicates its use is not recommended during lactation.


Q: Are there any known drug-disease interactions with Prometal (e.g., kidney, liver)?

Since the medicine is metabolized in the liver, regulatory documents caution that Prometal should be used with extra care in patients with impaired liver function. This precaution is established due to its primary metabolism pathways in the liver.


Q: Why do some people experience [specific non-serious side effect, e.g., dry mouth] with Prometal?

The official mechanism of action notes that Prometal blocks certain receptors in the body known as Muscarinic acetylcholine receptors. This specific blockade is associated with common anticholinergic effects, which often include side effects such as dry mouth and constipation.


Q: Can Prometal affect blood pressure?

Yes, regulatory documents note that Prometal works by affecting Alpha-1 adrenergic receptors, which play a role in regulating systemic vascular tone. Serious adverse reactions listed in the product safety information include the risk of developing hypotension (low blood pressure).


Q: How does Prometal affect laboratory test results?

Regulatory documents provide a specific warning that Prometal may interfere with certain laboratory tests. The most common noted interference is with immunologic urine pregnancy tests, which could potentially lead to false-positive or false-negative results.

How should Prometal be stored and disposed of?

The storage and disposal of Prometal (Promethazine HCl) must adhere strictly to the conditions specified in the official regulatory labeling.

Official Storage and Handling

Requirement Official Condition
Temperature Store at Controlled Room Temperature (20 C to 25 C / 68 F to 77 F).
Protection Protect from light; keep covered in the carton until the time of use. The container for the oral solution must be kept tightly closed.
Child Safety The medication must be kept out of the sight and reach of children to prevent accidental ingestion.

Disposal Instructions

Disposal of any unused or expired product must be done in accordance with local regulations for pharmaceutical waste. The recommended method is to utilize an official drug take-back program. As Prometal is not on the FDA's flush list, it must not be flushed down the toilet. If a take-back option is unavailable, the product should be mixed with an unpalatable substance (e.g., dirt, used coffee grounds) and sealed in a container before being discarded in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prometal found in:

A-Z Index: